ICAM-3 (CD50) is constitutively expressed on most B-cell malignancies, except for Hodgkin lymphoma, and myeloid cells, but appears to be absent from other tissues, with the possible exception of tumor-associated vasculature (45, 46). Here, ICAM3 is linked to neoplasm.